GENZEB LIMITED NUF

Last update: Jul 5, 2025

Management

Name	Role	Shares
GH Geir Hetland 1955	Managing Director/CEO	-

Name	Role	Shares
GH Geir Hetland 1955	Chairman	-
G GENZEB LIMITED	Information about the Company in the Home Country	-

Last update: Apr 13, 2023

Name	Share class	Total number of shares	Share
I IMMUNOPHARMA AS	NO0010735335	1	< 0.01 %

Last update: Jun 2, 2025

in NOK

Year	2024	2023	2022
Total operating income	1,141	0	0
Total operating costs	185,781	329,665	154,315
Operating result	-184,640	-329,665	-154,315
Financial income/costs	38,519,256	2,461,842	0
Profit before tax	38,334,615	2,132,177	-154,315
Total tax & extraordinary income/cost	0	0	0
Annual Total Result	38,334,615	2,132,177	-154,315

Year	2024	2023	2022
Total fixed assets	32,667,533	1,751,226	361,263
Total current assets	41,308	0	19
Total assets	32,708,841	1,751,226	361,282
Short term debt	0	0	742,233
Long term debt	0	0	0
Total liabilities	0	0	742,233
Contributed capital	0	0	0
Retained earnings	32,708,841	1,751,226	-380,951
Total equity	32,708,841	1,751,226	-380,951
Total equity and liabilities	32,708,841	1,751,226	361,282

Type of organization

Norwegian division of foreign business enterprise

Classification of institutional sector

INNL

Domestic sectors

A_IKKE-FIN

Non-financial corporations

2100

Private non-financial incorporated enterprises